Q/Which drugs work best for early Parkinson's disease?

Journal of Family Practice

Volumn 61, Issue 2, 2012, Pages 106-108

  Jain, Liza ^a   Benko, Rebecca ^a   Safranek, Sarah ^b   Guirguis Blake, Janelle ^a  

^a Tacoma Family Medicine Residency   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENZATROPINE MESILATE; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CARBIDOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; ANTIPARKINSON AGENT; CARBIDOPA, LEVODOPA DRUG COMBINATION; INDOLE DERIVATIVE;

AMNESIA; CARDIOVASCULAR RISK; CONFUSION; CONSTIPATION; DIARRHEA; DISEASE COURSE; DIZZINESS; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; EDEMA; GENETIC HETEROGENEITY; HALLUCINATION; HUMAN; INSOMNIA; META ANALYSIS (TOPIC); NAUSEA; NOTE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESSNESS; RISK; SIDE EFFECT; SOMNOLENCE; UNIFIED PARKINSON DISEASE RATING SCALE; VOMITING; DRUG COMBINATION; DRUG EFFECT; GENERAL PRACTICE; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; ORGANIZATION AND MANAGEMENT; REVIEW;

ANTIPARKINSON AGENTS; CARBIDOPA; DRUG COMBINATIONS; FAMILY PRACTICE; HUMANS; INDOLES; LEVODOPA; MOTOR SKILLS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE;

EID: 84856818753     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Hauser RA. Levodopa: past, present, and future. Eur Neurol. 2009;62:1-8.
2. Stowe RL, Ives NJ, Clarke C, et al. Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev. 2008;(2):CD006564.
3. van Hilten JJ, Ramaker CC, Stowe R, et al. Bromocriptine versus levodopa in early Parkinson's disease. Cochrane Database Syst Rev. 2007;(4):CD002258.
4. van Hilten JJ, Ramaker CC, Stowe R, et al. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. Cochrane Database Syst Rev. 2007;(4):CD003634.
5. Macleod AD, Counsell CE, Ives N, et al. Monoamine oxidase B inhibitors for early Parkinson's disease. Cochrane Database Syst Rev. 2005;(3):CD004898.
6. Hauser RA, Panisset M, Abbruzzese G, et al. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease. Mov Disord. 2009;24:541-550.
7. Katzenschlager R, Sampaio C, Costa J, et al. Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev. 2003;(2):CD003735.
8. Miyasaki JM, Martin W, Suchowersky O, et al. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002;58:11-17. (Pubitemid 34041931)
9. Drugs for Parkinson's disease. Treat Guidl Med Lett. 2011;9:1-6.
10. Drugstore.com Online Pharmacy. Pharmacy drug costs. Available at http://www.drugstore.com. Accessed August 30, 2011.